HomeRKV • CVE
add
Rakovina Therapeutics Inc
Previous close
$0.18
Year range
$0.0050 - $0.21
Market cap
15.80M CAD
Avg Volume
326.99K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 947.21K | 60.47% |
Net income | -1.02M | -56.99% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -812.08K | -78.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 255.05K | -68.64% |
Total assets | 5.31M | -8.86% |
Total liabilities | 2.23M | 49.15% |
Total equity | 3.07M | — |
Shares outstanding | 90.29M | — |
Price to book | 5.83 | — |
Return on assets | -41.06% | — |
Return on capital | -49.07% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.02M | -56.99% |
Cash from operations | -1.40M | -253.22% |
Cash from investing | — | — |
Cash from financing | 265.21K | — |
Net change in cash | -1.13M | -186.14% |
Free cash flow | -1.04M | -489.31% |
About
Founded
2019
Headquarters
Website
